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ABSTRACT  
Two RNA phosphoramidites containing the bases 1,N6-ethenoadenine and 3,N4-
ethenocytosine (εA and εC) were synthesized. These building blocks were 
incorporated into two 12-mer oligoribonucleotides for evaluation of the base pairing 
properties of these base lesions by UV-melting curve (Tm)- and circular dichroism 
(CD) measurements. The Tm data of the resulting duplexes with the etheno 
modifications opposing all natural bases showed a substantial destabilization 
compared to the corresponding natural duplexes, confirming their inability to form 
base-pairs. The coding properties of these lesions were further investigated by 
introducing them into 31-mer oligonucleotides and assessing their ability to serve as 
templates in primer extension reactions (PEX) with HIV-,AMV- and MMLV-reverse 
transcriptases (RT). Primer extension reactions showed complete arrest of the 
incorporation process using MMLV- and AMV-RT, while HIV-RT preferentially 
incorporates dAMP opposite to εA and dAMP as well as dTMP opposite εC. The 
properties of these RNA lesions are discussed in the context of its putative biological 
role. 
  
The accumulation of DNA nucleobase lesions has been correlated with the onset 
of various diseases, first and foremost to most types of cancer.(1-4) The formation of 
such lesions has been extensively investigated in the past and can be attributed to a 
large variety of endogenous or exogenous agents.(1) In particular, oxidative stress is 
considered as one of the most important processes leading to damaged 
nucleobases, yielding different classes of chemical modifications that can 
accumulate on the same target sequence.(4) Reactive oxygen species (ROS) are 
endogenous compounds such as hydrogen peroxide, superoxide and hydroxyl 
radicals. These ROS are constantly produced during the normal mitochondrial 
aerobic respiration, during inflammation induced by viral or bacterial infections, by 
cytochromes P-450, and by the peroxisome-mediated degradation of fatty acids (5). 
Furthermore, ROS can attack nucleic acids in a direct or indirect way: in the first 
case they react directly with the nucleobases, while in the second case, they react 
first with cellular metabolites, forming intermediate species that introduce other types 
of lesions into the nucleobases.(5)  8-oxo-dA, 8-oxo-dG, 5-hydroxy-dU and 5-
hydroxy-dC (6) are the main lesions that are produced via the first pathway while 
cyclic adducts such as etheno-dA, etheno-dC and etheno-dG (Figure 1) are mainly 
produced during the indirect path.  
Etheno(ε)-adducts were first identified as products of the reaction of 
chloroacetaldehyde with natural nucleobases, nucleosides, and with DNA and RNA 
strands (8-12). In living organisms chloroacetaldehyde occurs as a metabolite 
produced from vinyl chloride as a xenobiotic (13). More recently, ε-bases have been 
shown to occur during lipid peroxidation (LPO) by the interaction of the resulting 
reactive aldehydes and hydroxyalkenals with DNA (14-16). Indeed, high 
concentrations of ε-bases have been identified in those cells where high amounts of 
oxygen reactive species are produced indirectly, such as white blood cells during 
chronic inflammation.(2) The mutagenicity of these lesions when introduced into 
oligodeoxynucleotides has been fully investigated by in vitro and in vivo assays. and 
shown to be strongly mutagenic when tested in human kidney cell lines.(17) In this 
case, A/G transition and A/T transversion mutations were predominant.(18, 19) In 
other cells, such as Escherichia coli, minor mutagenic properties were observed for 
this lesion.(19, 20). Similarly, when tested in vivo, εC showed higher mutagenic 
properties with mammalian cells than with E. coli. Indeed, while mainly C/T 
transitions were observed in mammalian cells, only C/A transversions were 
produced in E. coli, albeit with a lower frequency.(20-23) 
 
Figure 1. Chemical structures of the main etheno-base lesions 
Although the formation of DNA base damage and its biological consequences is 
nowadays fairly well understood, surprisingly little is known on the effect of base 
lesions in RNA biochemistry and biology. Indeed, RNAs play a major role not only in 
translation (mRNAs, tRNA) but also in cellular regulation (miRNAs and other non-
coding RNAs). Moreover, RNA is more abundant than DNA, is located in the 
cytoplasm where most of the reactive species (in particular ROS) are present, and is 
less protected by proteins compared to histone organized DNA. Base damaged 
ribonucleosides such as 8-oxo-rA, 8-oxo-rG and 5-HOrU and 5-HOrC have recently 
been incorporated into oligoribonucleotides by solid-phase synthesis and their base 
pairing properties with complementary RNA as well as their coding preferences in 
templated primer extension reactions (PEX) by reverse transcriptases (RTs) have 
been assessed.(24-27) At the level of translation, oxidatively damaged mRNA has 
been demonstrated to cause largely diminished translation efficiency and abnormal 
protein synthesis, both in vitro and in vivo.(28, 29)  
Here, we report on the synthesis of short 12-mer oligoribonucleotides containing 
either single εA or εC nucleotides as well as their base recognition properties upon 
duplex formation with complementary DNA and RNA. Furthermore, 31-mer RNA 
templates modified with these units were synthesized and used in PEX with three 
different RTs to determine the coding properties of these lesions during reverse 
transcription. 
 
MATERIALS AND METHODS 
Oligonucleotide synthesis and purification.  Unmodified DNA and RNA 
oligonucleotides were purchased from Microsynth (Balgach, Switzerland) and HPLC 
or PAGE-purified when necessary. Natural 2’-TBDMS protected RNA 
phosphoramidites and CPG solid supports were obtained from GlenResearch or 
AZCO. The syntheses were performed on a 1.3 µmole scale on a Pharmacia Gene 
Assembler Plus DNA synthesizer following standard phosphoramidite protocols with 
5-(ethylthio)-1H-tetrazole (0.25M in CH3CN) as the activator and coupling times of 12 
min. Oligoribonucleotides were deprotected using 33% NH3/EtOH (3:1) for 16 h at 
25°C in a screw cap 1.5 ml tube. Solid supports were filtered off and washed with 
NH3/EtOH (3:1). The solutions were evaporated to dryness at room temperature in a 
Speedvac evaporator. The resulting pellets were further dried by addition of dry 
ethanol followed by evaporation. The pellets were then dissolved in anhydrous 
DMSO (100 µl) and neat triethylamine trihydrofluoride (125 µl) was added. After 
shaking at 25°C for 24 h, an aqueous solution of NaOAc (3 M, pH= 5.2, 25 µl) and n-
butanol (1 ml) was added and the mixture was chilled on dry ice for 45 min. After 
centrifugation for 20 min in an Eppendorf, the liquid was discarded and the pellet 
washed twice with chilled ethanol (80%, 1 ml) and dried under high vacuum at room 
temperature, yielding the crude oligonucleotides. The 31-mer oligoribonucleotides 
were purified on a preparative 20% denaturing polyacrylamide gel (PAGE), the 
product band electroeluted with an Elutrap electroelution system (Schleicher & 
Schuell), and desalted using Amicon ultra 0.5 filters (MWCO 3KDa, Millipore). The 
12-mer was HPLC purified on a DNAPac-200 column (4*250 mm, Dionex) with the 
gradient from 100% solvent A (25mM Tris, pH 8.0) to 50 % solvent B (25mM Tris, 
1.25M NaCl, pH 8.0) in 30 min at room temperature, and finally desalted on a Sep-
Pak C18 column (Waters Corp.). Oligonucleotide concentrations were determined 
using a NanoDrop ND-100 UV/Vis spectrophotometer (NanoDrop Technologies, 
Inc.). Stock solutions were made from DEPC treated H2O. 
UV-melting curves: Solutions were prepared in standard saline buffer (10mM 
NaH2PO4, 150mM NaCl, pH 7.0) with duplex concentrations of 2 µM in a 1:1 strand 
ratio. Thermal melting experiments were carried out on a Varian Cary 100-Bio 
UV/VIS spectrophotometer (Varian Inc.), equipped with a Peltier element at 260nm 
with a heating/cooling rate of 0.5° C/min. Tm values were obtained from the maxima 
of the first derivatives of the melting curves using the WinUV software. 
Labeling of oligonucleotides. The DNA primer d(ATCCCTGAGCGACTGGTGCA) 
was 5’-phosphorylated with [γ-32P]ATP (Hartmann Analytic) and T4 polynucleotide 
kinase (Fermentas) as follows: DNA primer (30 pmol), [γ-32P]ATP (60 mCi) and T4 
PNK (10 U) were incubated in a total volume of 20 µl at 37°C for 30 min in T4 PNK 
buffer (50mM Tris–HCl, pH 7.6, 10mM MgCl2, 5mM DTT, 0.1mM spermidine, 0.1mM 
EDTA). The T4 PNK was inactivated by heating the sample to 80°C for 2 min. The 
labeled primer was purified from unreacted free label by Amicon Ultra centrifugal 
filters, dried under vacuum and re-dissolved in 20 µl of DEPC water. Labeled DNA 
was then annealed to the RNA template (60 pmol) in the reaction buffer of the 
respective enzyme (see  the description of RT assays) by heating to 60°C for 5 min 
and slow cooling down to room temperature. 
RT assays. RT assays were performed with HIV-1 RT (Worthington Biochemical 
Corp), AMV RT (Promega Corp.) and MMLV RT (USB Corp./Affymetrix Inc.,) in the 
following buffers: HIV-1 RT and AMV RT: 50mM Tris (pH 8.3), 50mM NaCl, 8mM 
MgCl2, 1mM DTT; MMLV RT: 50mM Tris (pH 8.3), 75mM KCl, 3mM MgCl2, 10mM 
DTT. Final reaction mixtures contained RNA template (100 nM), DNA primer (50 nM) 
and dNTP (20 mM). After addition of the enzyme (2 - 40 U), the mixtures were 
incubated at 37°C for 1 h. The reactions were quenched with stop solution (98% 
formamide, 0.05% xylene cyanol (FF), 0.05% bromophenol blue), heated to 90°C for 
5 min and resolved by 20% PAGE. Visualization and quantification were carried out 
on a Storm 820 phosphorimager with ImageQuant software (GE Healthcare). 
 
RESULTS 
Synthesis of the modified phosphoramidites and oligoribonucleotides. The RNA 
oligonucleotides containing εA and εC modifications were synthesized using the 
RNA phosphoramidites 1 and 2 depicted in Figure 2. The synthesis of these building 
blocks was performed via a modification of a literature procedure.(30) The 
experimental details and the analytical data of the synthesized compounds can be 
found in the Supporting Information.  
 
Figure 2. Chemical structures of the εA- and εC RNA-phosphoramidites 1 and 2. 
The oligoribonucleotides prepared for this study are summarized in Table 1. The 12-
mer oligonucleotides ON 1-4, contain one of the damaged nucleobases or the 
corresponding natural bases in the center of the sequence and were used for Tm and 
CD-studies, while the 31-mer oligonucleotides ON 5-8 were used as templates in 
PEX. 
 
 
Table1. Natural and modified sequences used in this work 
Oligonucleotide RNA Sequence 
ON 1 5‘-AUGCUεAAGUCGA-3‘ 
ON 2 5‘-AUGCUεCAGUCGA-3‘ 
ON 3 5‘-AUGCUAAGUCGA-3‘ 
ON 4 5‘-AUGCUCAGUCGA-3‘ 
ON 5 5’-UAGUCUGCACεAUGCACCAGUCGCUCAGGGAU-3’ 
ON 6 5’-UAGUCUGCACεCUGCACCAGUCGCUCAGGGAU-3’ 
ON 7 5’-UAGUCUGCACAUGCACCAGUCGCUCAGGGAU-3’ 
ON 8 5’-UAGUCUGCACCUGCACCAGUCGCUCAGGGAU-3’ 
 
Coupling yields of the modified building blocks 1 and 2 were >98% as determined by 
trityl assay. Oligoribonucleotides were first base-, phosphate and finally 2’-O 
deprotected. The 12-mer sequences were purified by IE-HPLC, while the 31-mer 
oligonucleotides were PAGE purified. In order to limit the extent of ethenobase 
degradation in alkaline media,(31) we carried out the cleavage and base-
deprotection in 33%NH3:Ethanol =3:1 at 25°C overnight, obtaining the desired 
products in acceptable isolated yields: 14.8% for oligonucleotide ON 1 and 10.5% for 
oligonucleotide ON 2. HPLC traces of crude oligonucleotides (Figure 3) and mass 
spectrometric data (see Supporting Information) demonstrated the relative stabilities 
of the modified oligonucleotides during deprotection.  
 Figure 3. HPLC of crude ON 1 (left) and ON 2 (right) 
UV-melting curves and CD spectroscopy. In order to study the influence of ε-lesions 
on the hybridization properties of RNA, melting curves of the duplexes containing the 
modified oligonucleotides ON 1 or ON 2 and the corresponding RNA or DNA 
complements were measured and compared with the corresponding natural 
duplexes containing oligoribonucleotides ON 3 and ON 4 (Table 2, Figure 4). 
 
Table2. Tm data (°C, 260 nm) of duplexes of the oligoribonucleotides ON 1-ON 
4 with r(UCGACUXAGCAU) or d(TCGACTXAGCAT) as complement; duplex 
concentration: 2 M in 10mM NaH2PO4, 150mM NaCl, pH 7.0 
 RNA Complements DNA Complements 
X= rA rC rG rU dA dC dG dT 
ON 1 (εA) 43.9 40.6 44.9 42.0 28.6 23.6 29.3 25.4 
ON 3 (A) 44.9 46.6 46.7 57.6 29.6 34.6 29.9 45.3 
ON 2 (εC) 43.9 39.3 46.6 41.9 25.2 20.8 25.3 24.3 
ON 4 (C) 46.9 43.0 64.6 43.9 27.2 24.5 48.6 27.2 
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The Tm analysis further underscores the drastic influence that the exocyclic lesions 
have on the hybridization properties of nucleic acids. Indeed, the loss of their ability 
to form standard Watson-Crick hydrogen bonds (32, 33) causes a major 
destabilization of the RNA-RNA duplexes with the cognate complementary base 
opposite to the lesion (-15.6°C in the case of εA and -18.0°C in the case of εC, Table 
2) . The same trend can be observed in the case of RNA-DNA duplexes. Moreover, 
the Tm values are not further reduced when all the other nucleobases face the lesion, 
clearly showing that the natural base-lesion pair constitutes a mismatch, regardless 
of the nature of the base. In all cases, the duplexes formed with a G opposite the 
lesion are slightly more stable than the others, most likely due to stronger base 
stacking interactions. 
 Figure 4. Tm curves for duplexes of oligonucleotides containing a lesion (ON1 and 
ON2) or the corresponding natural base (ON 3 and ON 4) with r(UCGACUXAGCAU) 
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or d(TCGACTXAGCAT); duplex conc.: 2 µM in 10mM NaH2PO4, 150mM NaCl, pH 
7.0. 
To study the influence of these exocyclic base lesions on the structure of the 
duplexes, CD measurements were performed. ON 1 and ON 2 were hybridized with 
complementary RNA sequences and the CD-spectra of the resulting duplexes all 
showed a standard A-conformation (Figure 5) and do not deviate substantially from 
the corresponding unmodified duplexes (data not shown). 
 
Figure 5. CD spectra of duplexes containing ON 1 or ON 2 with 
r(UCGACUXAGCAU). Duplex concentration: 2 µM (1:1 strand ratio) in 10mM 
NaH2PO4, 150mM NaCl, pH 7.0; T=25°C. 
 
Primer template extension experiments. Further investigations of the coding 
properties of the ε-bases were performed using standing-start template primer 
extension reactions in a similar setup as reported previously for other RNA 
lesions.(27, 34) 5’-32P radiolabeled DNA primer, dNTPs, 31-mer templates 
containing the lesions and three different RTs having different transcription fidelities 
(HIV1-RT, AMV-RT and MMLV-RT) were used and the corresponding gels are 
shown in Figures 6 and 7. Quantitative data of dNMP incorporation opposite the 
lesion is given in the Supporting Information.  
When the transcriptases AMV-RT and MMLV-RT were used, complete inhibition of 
reverse transcription was observed for both the A and C lesions. Even in the 
presence of all the natural dNTPs, no bands or only minor traces corresponding to 
elongated primer could be observed (Figures 6 and 7). On the other hand, a different 
behavior was observed in the case of HIV-RT. This error prone polymerase is able to 
read through both damages. In the case of the εA containing RNA template (ON 5), 
dAMP (78.3 %) was the most efficiently incorporated nucleotide, followed by dGMP 
(71.3 %). No incorporation of the base thymine (dTMP) could be observed (Figure 6). 
Thus, the order of preferential incorporation opposite εA is A>G>>C,T. In the 
presence of all dNTPs, full length synthesis was observed although being slightly 
less efficient compared to the undamaged template.  
The results obtained using the εC containing RNA template (ON 6) are shown in 
Figure 7. In contrast with what was observed in the case of the εA containing 
template, HIV1 RT was completely unable to incorporate dGMP opposite εC. As 
observed for ON 5, the most efficiently incorporated nucleotide was dAMP (79.2 %). 
Moreover, the incorporation of dTMP was rather efficient (61.8 %) but not as good as 
that for dAMP. The analysis of these results lead to the following preferential order of 
incorporation opposite εC: A>T>>C>G. Again, in the presence of all the dNTPs, 
synthesis of the full-length product is observed and the lesion seems to have no 
inhibitory effect. 
  
Figure 6. Autoradiograms of standing-start primer extension reactions for the RTs 
indicated using ON 5 containing the εA lesion as the template and the corresponding 
natural template (ON 7). Reactions were performed at 37°C for 1 h. Enzyme 
concentrations: HIV-RT, 2 U; AMV-RT, 8 U; MMLV-RT, 40 U. Ref: primer without 
enzyme; A, T, G, C: reactions in presence of the respective dNTP; N: reactions in 
presence of all four dNTPs; Nat: unmodified RNA template and all four dNTPs. 
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Figure 7. Autoradiograms of standing-start primer extension reactions for the RTs 
indicated using ON 6 containing the εC lesion as a template and the corresponding 
natural template (ON 8). Reactions were performed at 37°C for 1 h. Enzyme 
concentrations: HIV-RT, 2 U; AMV-RT, 8 U; MMLV-RT, 40 U. Ref: primer without 
enzyme; A, T, G, C: reactions in presence of the according dNTP; N: reactions in 
presence of all four dNTPs; Nat: unmodified RNA template  and all four dNTPs. 
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DISCUSSION 
We describe here the chemical synthesis of oligoribonucleotides containing 1,N6-
ethenoadenosine and 3,N4-ethenocytidine using standard phosphoramidite 
chemistry. Although the synthesis of such RNA oligonucleotides was previously 
reported,(30) to the best of our knowledge the pairing and coding properties of 
oligoribonucleotides containing such lesions have never been reported. From UV-
melting curve analysis it appears that both etheno modifications completely lack 
recognition capacities towards all natural bases. The slightly more stable 
arrangements with purine bases opposite the etheno lesions may be explained by 
more favorable stacking interactions. These results are in agreement with earlier 
findings on the hybridization properties of oligodeoxynucleotides containing εdA or 
εdC lesions.(35-37) Even there, strong duplex destabilization against any natural 
base was observed. Again, in these cases the most stable duplex resulted when a G 
was placed opposite to the lesion.(35, 36) confirming the importance of (presumably 
interstrand) stacking interactions on duplex stability. 
The structure of the duplexes containing these lesions was investigated by CD 
spectroscopy. The results indicate that their presence do not affect the overall A-
helix conformation of the duplexes. Thus, the expected local structural perturbations 
at the site of the base lesion are (not unexpectedly) invisible by CD-spectroscopy. 
Clearly more high resolution structural work by NMR or X-ray crystallography is 
needed to reveal the precise arrangement of the modified bases. 
The primer extension experiments nicely show the mutagenic potential of A and 
C during reverse transcription. While none of the two etheno nucleosides 
investigated can be read by AMV or MMLV RT, leading to abortion of DNA synthesis, 
both of them are accepted by the more permissive HIV RT. However, depending on 
the nature of the lesion, the coding preferences are somewhat different. Indeed, A 
preferentially leads to purine incorporation opposite itself with a slight advantage for 
dAMP (A-rule). This behavior has been observed in a similar experiment with an 
abasic site as a non-coding lesion in an RNA template.(34) 
Primer extension experiments using εdA inserted in a DNA template were 
reported previously.(38) Surprisingly, from these experiments it resulted that the only 
enzyme completely inhibited by the presence of this lesion is HIV-RT. Quite 
interestingly, MMLV-RT could elongate the DNA primer in different sequence 
contexts, although not to full length. This again is contrary to what we observed with 
the RNA template. It therefore seems that HIV RT shows a higher degree of 
sensitivity towards lesions on DNA compared to RNA. This may imply that retroviral 
mutations are more likely to occur during DNA synthesis on the viral RNA template 
than during complementary DNA strand synthesis on the reverse transcribed DNA 
strand. 
Also in the case of etheno cytidine there is precedence in the literature on its 
coding properties when present in a DNA template. (39) It needs to be noted though 
that these PEX were performed with DNA polymerases and not with reverse 
transcriptases. Compared with our results with HIV RT, lesion bypass synthesis is 
more strongly slowed down for all of the DNA polymerases investigated in this study. 
The nature of the bases preferentially introduced opposite the lesion is highly 
dependent on the polymerase used. Indeed, Pol α incorporates dAMP and dTMP 
opposite to the lesion, pol β dAMP and dCMP, pol η dAMP and dGMP, and pol κ 
dTMP.(39) Thus, the preferences of HIV1 incorporation in our experiments compare 
well to those of pol . Again, we need to point out that these conclusions do not take 
into consideration variations in base preferences as a function of the sequence 
context. 
The mutagenicity of base lesions in DNA is a major threat to genome integrity of 
living systems. In part this is also true for base damaged RNA in organisms, the 
genome of which consists of RNA (e.g. RNA viruses). Moreover, base damage to 
RNA can have additional biological implications. For example, it can deeply affect 
the cellular metabolism if non-coding RNAs involved in regulatory processes are 
affected. In addition, if present on mRNAs, such base lesions can lead to 
misincorporations of amino acids during translation (translational mutations), or 
alternatively it can lead to ribosome arrest which may severely impair cellular vitality. 
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SUPPORTING INFORMATION AVAILABLE 
Synthetic and analytical details for phosphoramidites 1 and 2, mass spectra for 
etheno modified oligonucleotides as well as quantitative data on dNMP incorporation 
for primer extension reactions. This material is available free of charge via the 
Internet at http://pubs.acs.org.  
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